News

Photo
26.09.2023 • News

Traceless Materials secures €36.6 Million to Build Plant

Bioeconomy startup Traceless Materials, which produces a natural biomaterial as an alternative to plastic, announces the completion of a €36.6 million funding round. The Series A financing round is led by UB Forest Industry Green Growth Fund.

Photo
25.09.2023 • News

Novo Holdings, Gurnet Point Close Acquisition of Paratek Pharmaceuticals

Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and healthcare investment firm Gurnet Point closed their acquisition of US antibiotics specialist Paratek Pharmaceuticals in a transaction valued at $462 million. Novo Holdings said that this is its largest individual investment in antimicrobial resistance (AMR) therapies to date.

Photo
22.09.2023 • News

Ineos Acquires Eramet Titanium & Iron for €230 Million

Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.

Photo
21.09.2023 • News

Astellas to Build an Aseptic Drug Products Plant in Ireland

Japanese drugmaker Astellas Pharma plans to build an aseptic drug products facility in County Kerry, Ireland, creating an estimated 350 engineering, science, technology and other jobs. Construction is expected to begin next year and be completed in 2028. Astellas expects the investment costs to amount to €330 million.

Photo
20.09.2023 • News

ExxonMobil Completes Expansion of US Chemical Production at Baytown

US multinational energy company ExxonMobil has started up two new chemical production units at its Baytown, Texas, manufacturing facility. The $2 billion expansion is part of the company’s long-term growth plans for its US Gulf Coast refining and chemical facilities.

Photo
19.09.2023 • News

Solvay and Shengjian Expand Their Strategic Partnership

Belgian chemical major Solvay and China-headquartered Shanghai Shengjian Environment Technology, a company specializing on semiconductor process waste gas treatment, signed a strategic partnership framework agreement to strengthen their business relations and expand into new markets.

Photo
19.09.2023 • News

MSD Ireland Opens New Site in Dunboyne, Completes Expansion in Carlow

In Ireland, US drugmaker MSD has opened its new facility in Dunboyne, County Meath, and has expanded its Carlow site. MSD says it has invested more than €1 billion at both sites, creating 670 new jobs and increasing the number of employees in Ireland to 3,100. 100 of the newly created positions remain to be filled.

Photo
18.09.2023 • News

Moderna and Immatics Collaborate on Cancer Therapies

US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies, combining Immatics’ TCR platform with Moderna’s mRNA technology. The project spans various therapeutic modalities including bispecifics, cell therapy and cancer vaccines.

Photo
18.09.2023 • NewsStrategy

Intelligent Engineering for Optimized Pharma Manufacturing

The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.

Photo
15.09.2023 • News

Azelis Appoints Evy Hellinckx as New CEO for EMEA

Specialty chemicals and food ingredients distributor Azelis has appointed Evy Hellinckx as CEO of Azelis EMEA, effective Jan. 1, 2024. She succeeds Anna Bertona, who will take on her new role as Azelis Group CEO at the beginning of next year.

Photo
13.09.2023 • NewsStrategy

Biosurfactants at Scale

In response to the urgent need for sustainable solutions in the ­surfactants industry, companies like Locus Ingredients are developing environmentally friendly biosurfactants.

Photo
12.09.2023 • News

Plastale: Towards Sustainable Development through Material Innovation and Circular Economy

The Egypt-based start-up Plastale produces composite materials for different applications out of local plastic and crop waste. Their recycling process aims to be energy and cost efficient, and the start-up focuses also on creating social impact through collaboration with local communities and local waste collectors. For this reason, International Sustainable Chemistry Collaborative Centre (ISC3) features Plastale as the ISC3 Start-up of the Month for September 2023.

Photo
08.09.2023 • News

Univar Buys Canadian Chemicals Distributor FloChem

US specialty ingredients and chemicals distributor Univar Solutions has acquired Canadian company FloChem and certain of its affiliates, giving Univar access to new market segments and new service capabilities. Terms of the transaction were not disclosed.

Photo
07.09.2023 • News

LyondellBasell Plans Permanent Closure of PP Plant in Italy

LyondellBasell plans to permanently close one of its two polypropylene (PP) plants at Brindisi, Italy, due to increasingly difficult market conditions and a poor outlook. The company has not disclosed which plant is affected, nor has it provided a timeline for the planned closure.

Photo
06.09.2023 • News

Solvay Expands China Research and Innovation Center in Shanghai

With the inauguration of a new research building in the Shanghai Technology Park, Solvay has completed the expansion of its China Research & Innovation Center (R&I). The company said that it has invested more than 4 billion RMB (approximately €500 million) in its Chinese R&I hub since 2005.

Photo
06.09.2023 • News

CordenPharma Completes Upgrade of US Peptide Production Site in Colorado

CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide production capacity with newly-upgraded facilities at its Colorado site in the US, which the company says is the world's largest solid-phase peptide synthesis (SPPS) manufacturing facility.

Photo
05.09.2023 • News

Albemarle Makes Final Proposal for the Acquisition of Liontown

Australian lithium miner Liontown announced that it has received a revised conditional and non-binding indicative proposal from Albemarle to acquire all of the ordinary shares outstanding in Liontown for A$3.00 in cash per share via scheme of arrangement. The revised proposal values Liontown at A$6.6 billion ($4.3 billion) on an equity value basis.

Photo
05.09.2023 • News

FTC Approves Amgen's Acquisition of Horizon

The US Federal Trade Commission (FTC) wants to clear the takeover of Irish biotech company Horizon Therapeutics by pharmaceutical group Amgen. Following concessions by Amgen, the authority is dropping its earlier objections to the $27.8 billion purchase, the FTC announced last Friday.

Photo
04.09.2023 • News

Danaher to Acquire Abcam for $5.7 Billion

US science and technology group Danaher has entered into a definitive agreement to acquire Abcam, a supplier of life science research tools. Danaher will buy all of the outstanding shares of Abcam for $24.00 per share. The transaction, which is worth about $5.7 billion, is expected to close in mid-2024.

12868 more News

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.